COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
its 2017 Annual Meeting of Stockholders (the Annual
Meeting). We have disclosed the final voting results for each
proposal presented at the Annual Meeting:
Kenneth Samet and Nachum Shamir, to the Board of Directors of the
Company. The director nominees were elected by a plurality of the
votes cast:
|
FOR
|
WITHHOLD
|
BROKER
NON-VOTE
|
|
|
Cheryl Pegus
|
45,837,760
|
1,070,212
|
11,695,012
|
|
Kenneth Samet
|
46,663,695
|
244,277
|
11,695,012
|
|
Nachum Shamir
|
46,590,663
|
317,309
|
11,695,012
|
Companys Certificate of Incorporation and the amendment and
restatement of the Companys Bylaws to declassify the Board of
Directors, and to make related changes, effective immediately
after the Annual Meeting. The proposal was approved by 77.1% of
the votes which all of the stockholders would be entitled to cast
at the Annual Meeting.
the prior Proposal, and all directors going forward, will be
elected annually and until their successors are duly elected and
qualified.
|
FOR
|
AGAINST
|
ABSTAIN
|
BROKER
NON-VOTE
|
|
46,602,174
|
280,521
|
25,277
|
11,695,012
|
Companys independent registered public accounting firm for the
year ending December 31, 2017. The proposal was approved by 99.7%
of the shares of common stock voting on the matter.
|
FOR
|
AGAINST
|
ABSTAIN
|
BROKER
NON-VOTE
|
|
58,444,542
|
62,683
|
95,759
|
Company withdrew Proposal No. 3 (to approve the amendment and
restatement of the Companys Certificate of Incorporation and the
amendment and restatement of the Companys Bylaws to eliminate the
requirement that stockholder written consents must be unanimous)
immediately prior to the Annual Meeting.
About COGENTIX MEDICAL, INC. (NASDAQ:CGNT)
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.
